Candel Therapeutics

-$0.05 (-1.33%) Today
$0.00 (0.00%) As of 8:00 PM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CADL and other ETFs, options, and stocks.

About CADL

Candel Therapeutics, Inc. operates as a biopharmaceutical company that develops and commercializes cancer immunotherapy drugs. It offers aglatimagene besadenovec (CAN-2409), a replication-deficient adenovirus that delivers within infected cancer cells the herpes simplex virus thymidine kinase (HSV-tk) gene.

CEO
Paul-Peter Tak
Employees
65
Headquarters
Needham, Massachusetts
Founded
2002

CADL Key Statistics

Market cap
106.16M
Price-Earnings ratio
—
Dividend yield
—
Average volume
27.07K
High today
$3.91
Low today
$3.61
Open price
$3.71
Volume
14.04K
52 Week high
$14.78
52 Week low
$3.33

CADL Earnings

-$0.32
-$0.21
-$0.11
$0.00
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Estimated
-$0.31 per share
Actual
-$0.30 per share
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure